Circulation, Vol 86, 730-740, Copyright © 1992 by American Heart Association
L Fananapazir, AC Chang, SE Epstein and D McAreavey
BACKGROUND. Patients with hypertrophic cardiomyopathy (HCM) frequently have
arrhythmias and hemodynamic abnormalities and are prone to sudden death and
syncope. An important need exists for improved risk stratification and
definition of appropriate investigation and therapy. METHODS AND RESULTS.
The relation of 31 clinical, Holter, cardiac catheterization, and
electrophysiological (EP) variables to subsequent cardiac events in 230 HCM
patients was examined by multivariate analysis. Studies were for cardiac
arrest (n = 32), syncope (n = 80), presyncope (n = 52), ventricular
tachycardia (VT) on Holter (n = 36), a strong family history of sudden
death (n = 9), and palpitations (n = 21). Nonsustained VT on Holter was
present in 115 patients (50%). Sustained ventricular arrhythmia was induced
in 82 patients (36%). Seventeen cardiac events (eight sudden deaths, one
cardiac arrest, and eight syncope with defibrillator discharges) occurred
during a follow- up of 28 +/- 19 months. The 1-year and 5-year event-free
rates were 99% and 79%, respectively. Two variables were significant
independent predictors of subsequent events: sustained ventricular
arrhythmia induced at EP study (beta, 3.5; p = 0.002) and a history of
cardiac arrest or syncope (beta, 2.9; p less than 0.05). Only two of 66
patients without symptoms of impaired consciousness had a cardiac event
(3-year event-free rate, 97%). In contrast, nonsustained VT on Holter was
associated with a worse prognosis only in patients with symptoms of
impaired consciousness: 11 of 79 symptomatic patients with VT on Holter
(14%) had events versus only four of 85 symptomatic patients without VT on
Holter (5%) (p = 0.057). Notably, none of 51 patients without symptoms of
impaired consciousness in whom VT was not induced at EP study had a cardiac
event. CONCLUSIONS. In HCM, VT on Holter is of benign prognostic
significance in the absence of symptoms of impaired consciousness and
inducible VT, and sustained VT induced at EP study, especially when
associated with cardiac arrest or syncope, identifies a subgroup at high
risk for subsequent cardiac events.
ARTICLES
Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings
Electrophysiology Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.
This article has been cited by other articles:
![]() |
M. Haghjoo, S. Mohammadzadeh, M. Taherpour, B. Faghfurian, A. F. Fazelifar, A. Alizadeh, M. A. Rad, and M. A. Sadr-Ameli ST-segment depression as a risk factor in hypertrophic cardiomyopathy Europace, May 1, 2009; 11(5): 643 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Saumarez, M. Pytkowski, M. Sterlinski, J. P. Bourke, J. R. Clague, S. M. Cobbe, D. T. Connelly, M. J. Griffith, P. P. McKeown, K. McLeod, et al. Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy Eur. Heart J., July 1, 2008; 29(13): 1653 - 1661. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Stephenson and C. I. Berul Electrophysiological Interventions for Inherited Arrhythmia Syndromes Circulation, August 28, 2007; 116(9): 1062 - 1080. [Full Text] [PDF] |
||||
![]() |
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF] |
||||
![]() |
F. Enseleit and F. Duru Long-term continuous external electrocardiographic recording: a review. Europace, April 1, 2006; 8(4): 255 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Nugent, P. E.F. Daubeney, P. Chondros, J. B. Carlin, S. D. Colan, M. Cheung, A. M. Davis, C.W. Chow, R. G. Weintraub, and for the National Australian Childhood Cardiomyopat Clinical Features and Outcomes of Childhood Hypertrophic Cardiomyopathy: Results From a National Population-Based Study Circulation, August 30, 2005; 112(9): 1332 - 1338. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hiasa, M. Hamada, H. Saeki, A. Ogimoto, T. Ohtsuka, Y. Hara, and Y. Shigematsu Cardiac Sympathetic Nerve Activity Can Detect Congestive Heart Failure Sensitively in Patients With Hypertrophic Cardiomyopathy Chest, September 1, 2004; 126(3): 679 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P Frenneaux Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy Heart, May 1, 2004; 90(5): 570 - 575. [Full Text] [PDF] |
||||
![]() |
B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1687 - 1713. [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Eur. Heart J., November 1, 2003; 24(21): 1965 - 1991. [Full Text] [PDF] |
||||
![]() |
R. C. Saumarez, L. Chojnowska, R. Derksen, M. Pytkowski, M. Sterlinski, C. L.-H. Huang, N. Sadoul, R. N.W. Hauer, W. Ruzyllo, and A. A. Grace Sudden Death in Noncoronary Heart Disease Is Associated With Delayed Paced Ventricular Activation Circulation, May 27, 2003; 107(20): 2595 - 2600. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Marian On predictors of sudden cardiac death in hypertrophic cardiomyopathy J. Am. Coll. Cardiol., March 19, 2003; 41(6): 994 - 996. [Full Text] [PDF] |
||||
![]() |
J. M Morgan PATIENTS WITH VENTRICULAR ARRHYTHMIAS: WHO SHOULD BE REFERRED TO AN ELECTROPHYSIOLOGIST? Heart, December 1, 2002; 88(5): 544 - 550. [Full Text] [PDF] |
||||
![]() |
M.J. Janse and J.M.T. De Bakker Arrhythmia substrate and management in hypertrophic cardiomyopathy: from molecules to implantable card ioverter-defibrillators Eur. Heart J. Suppl., October 1, 2001; 3(suppl_L): L15 - L20. [Abstract] [PDF] |
||||
![]() |
S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450. [PDF] |
||||
![]() |
R.C. Saumarez and A.A. Grace Paced ventricular electrogram fractionation and sudden death in hypertrophic cardiomyopathy and other non-coronary heart diseases Cardiovasc Res, July 1, 2000; 47(1): 11 - 22. [Full Text] [PDF] |
||||
![]() |
S.-T. Li, C. J. Tack, L. Fananapazir, and D. S. Goldstein Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1867 - 1873. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Atiga, L. Fananapazir, D. McAreavey, H. Calkins, and R. D. Berger Temporal Repolarization Lability in Hypertrophic Cardiomyopathy Caused by {beta}-Myosin Heavy-Chain Gene Mutations Circulation, March 21, 2000; 101(11): 1237 - 1242. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Gil, F. Arribas, and F. G. Cosio Ventricular fibrillation induced by rapid atrial rates in patients with hypertrophic cardiomyopathy Europace, January 1, 2000; 2(4): 327 - 332. [Abstract] [PDF] |
||||
![]() |
M. H. Crawford, S. J. Bernstein, P. C. Deedwania, J. P. DiMarco, K. J. Ferrick, A. Garson Jr, L. A. Green, H. L. Greene, M. J. Silka, P. H. Stone, et al. ACC/AHA guidelines for ambulatory electrocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) developed in collaboration with the North American Society for Pacing and Electrophysiology J. Am. Coll. Cardiol., September 1, 1999; 34(3): 912 - 948. [Full Text] [PDF] |
||||
![]() |
P. J. Zimetbaum and M. E. Josephson The Evolving Role of Ambulatory Arrhythmia Monitoring in General Clinical Practice Ann Intern Med, May 18, 1999; 130(10): 848 - 856. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fananapazir Advances in Molecular Genetics and Management of Hypertrophic Cardiomyopathy JAMA, May 12, 1999; 281(18): 1746 - 1752. [Full Text] [PDF] |
||||
![]() |
E. Takagi, T. Yamakado, and T. Nakano Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., January 1, 1999; 33(1): 206 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hirayama, K. Marumoto, H. Okayama, T. Iwata, and M. Suzuki Paroxysmal Atrial Fibrillation as a Cause of Potentially Lethal Ventricular Arrhythmia with Myocardial Ischemia in Hypertrophic Cardiomyopathy: A Case Report Angiology, August 1, 1998; 49(8): 653 - 657. [Abstract] [PDF] |
||||
![]() |
E. Lazzeroni, E. Picano, L. Morozzi, A. R. Maurizio, G. Palma, R. Ceriati, E. Iori, and A. Barilli Dipyridamole-Induced Ischemia as a Prognostic Marker of Future Adverse Cardiac Events in Adult Patients With Hypertrophic Cardiomyopathy Circulation, December 16, 1997; 96(12): 4268 - 4272. [Abstract] [Full Text] |
||||
![]() |
J. J. Allan, R. Paz, P. A. Tunick, and I. Kronzon Ethanol and Hypertrophic Cardiomyopathy N. Engl. J. Med., March 20, 1997; 336(12): 878 - 878. [Full Text] |
||||
![]() |
P. Spirito, C. E. Seidman, W. J. McKenna, and B. J. Maron The Management of Hypertrophic Cardiomyopathy N. Engl. J. Med., March 13, 1997; 336(11): 775 - 785. [Full Text] [PDF] |
||||
![]() |
D. A. Theodoro, G. K. Danielson, R. H. Feldt, and B. J. Anderson HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY IN PEDIATRIC PATIENTS: RESULTS OF SURGICAL TREATMENT J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1589 - 1599. [Abstract] [Full Text] |
||||
![]() |
C. R. Cannan, G. S. Reeder, K. R. Bailey, L. J. Melton III, and B. J. Gersh Natural History of Hypertrophic Cardiomyopathy : A Population-Based Study, 1976 Through 1990 Circulation, November 1, 1995; 92(9): 2488 - 2495. [Abstract] [Full Text] |
||||
![]() |
E. D. Wigle, H. Rakowski, B. P. Kimball, and W. G. Williams Hypertrophic Cardiomyopathy : Clinical Spectrum and Treatment Circulation, October 1, 1995; 92(7): 1680 - 1692. [Full Text] |
||||
![]() |
R. C. Saumarez, A. K. B. Slade, A. A. Grace, N. Sadoul, A. J. Camm, and W. J. McKenna The Significance of Paced Electrogram Fractionation in Hypertrophic Cardiomyopathy : A Prospective Study Circulation, June 1, 1995; 91(11): 2762 - 2768. [Abstract] [Full Text] |
||||
![]() |
D C Lefroy Grand Rounds - Hammersmith Hospital: Cardiac arrest and hypertrophic cardiomyopathy BMJ, November 12, 1994; 309(6964): 1277 - 1279. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |